Company intelligence / Profile preview
BioStem Technologies
Pompano Beach, Florida, United Statesbiostemtechnologies.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BioStem Technologies has achieved commercial success with its placental-derived allograft products such as VENDAJE®, VENDAJE AC®, VENDAJE OPTIC®, and AmnioWrap2™. The company is running pivotal multicenter clinical trials in diabetic foot ulcers to demonstrate superiority over standard of care, aiming to support broader insurance coverage and market expansion. Early results have driven significant revenue growth, but full trial outcomes are pending.[5][6][9]
- Therapeutic areas
- EndocrinologyPsychiatryDermatology
- Modalities
- Perinatal tissue allograftsPlacental-derived biologics
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on BioStem Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioStem Technologies.